Nano Services

Vanta Bioscience Ltd.

VANTABIO

Market Cap
₹18 Cr.
P/E
166.54

Vanta Bioscience Ltd.

  • Vanta Bioscience
  • MIG Media Neurons
  • FGP

FAQs on Vanta Bioscience Ltd. Shareprice

Vanta Bioscience has given lower returns compared to its competitors.
Vanta Bioscience has grown at ~-29.59% over the last 5yrs while peers have grown at a median rate of 0.0%

Vanta Bioscience is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Vanta Bioscience is 166, while 3 year average PE is 158.
Also latest EV/EBITDA of Vanta Bioscience is 0.0 while 3yr average is 28.85.

View FAQ's On Business

Growth Table

  • Vanta Bioscience Ltd.
  • MIG Media Neurons
  • FGP

Balance Sheet

  • Vanta Bioscience Ltd.
  • MIG Media Neurons
  • FGP

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Vanta Bioscience Ltd.
  • MIG Media Neurons
  • FGP

Cash Flow

  • Vanta Bioscience Ltd.
  • MIG Media Neurons
  • FGP

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Vanta Bioscience Ltd.
  • MIG Media Neurons
  • FGP

Quarterly Results

  • Vanta Bioscience Ltd.
  • MIG Media Neurons
  • FGP

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Vanta Bioscience Ltd. Financials

Vanta Bioscience balance sheet is weak and might have solvency issues

The net debt of Vanta Bioscience is decreasing.
Latest net debt of Vanta Bioscience is ₹37.94 Crs as of Mar-26.
This is less than Mar-25 when it was ₹69.85 Crs.

The profit is oscillating.
The profit of Vanta Bioscience is -₹4.77 Crs for Mar 2025, -₹2.32 Crs for Mar 2024 and -₹6.48 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vanta Bioscience latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech